Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)
NCT00704535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4105
Last updated 2022-02-09
Summary
The purpose of this study is to evaluate the overall safety, tolerability, and efficacy of Ezetimibe when used alone or in combination with a statin in patients with hypercholesterolemia
Conditions
- Primary Hypercholesterolemia
- Homozygous Familial Hypercholesterolemia
Interventions
- DRUG
-
Ezetimibe
1 tablet of 10 mg once daily
Sponsors & Collaborators
-
Organon and Co
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
NCT03882996 ·Status: COMPLETED ·Phase: PHASE3
-
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
NCT00705211 ·Status: COMPLETED
-
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)
NCT00871351 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)
NCT00092586 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)
NCT03882892 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)
NCT00395473 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
NCT00479713 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
NCT00650689 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
NCT00092638 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)
NCT03884452 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
NCT00651963 ·Status: COMPLETED ·Phase: PHASE4
-
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
NCT00319449 ·Status: COMPLETED ·Phase: PHASE4
-
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
NCT00652327 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)
NCT00726856 ·Status: COMPLETED
-
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
NCT00093899 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
NCT00202904 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
NCT01370603 ·Status: COMPLETED ·Phase: PHASE3
-
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
NCT00092833 ·Status: TERMINATED ·Phase: PHASE3
-
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
NCT00092599 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)
NCT00652847 ·Status: COMPLETED ·Phase: PHASE4
-
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
NCT00653796 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3
-
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
NCT00092612 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)
NCT00551447 ·Status: COMPLETED ·Phase: PHASE3